Plunkett Research Online: Athenex

ATHENEX (ATNX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell rec.....


ATHENEX

Ticker: ATNX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 716 427-2950
Fax: 716 800-6816
Address: 1001 Main Street
Buffalo, NY 14203 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Johnson LauCEO/Chairman of the Board/Director
Steven AdamsChief Accounting Officer/Other Corporate Officer
See More
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell rec.....See More See More

$USD, In whole numbers2020201920182017201620152014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture